Prodrugs: from Design to Clinic
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (15 January 2014) | Viewed by 72702
Special Issue Editors
Interests: prodrugs; CNS drug delivery; drug transporters
Special Issues, Collections and Topics in MDPI journals
Interests: transporter; solute carriers (SLC); ATP-binding cassette (ABC); drug delivery; drug targeting; ADME; pharmacokinetics; toxicokinetics; drug development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We would like to invite you to submit an original manuscript, communication or review for this special issue. Your contribution to this topic will greatly enhance the understanding of this important topic to the readers of Pharmaceuticals. We would like the focus of this issue to be on the structure-activity relationships between promoiety structure and absorption, targeting and/or activation. Additional focus on the physicochemical changes that the prodrug moiety adds to the molecule and how that results in different PK, distribution kinetics and toxicities are also welcome.
Prof. Dr. Jarkko Rautio
Dr. Kristiina Huttunen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prodrugs
- bioprecursor
- bioconversion
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issues
- Prodrugs in Molecules (47 articles)
- Prodrugs in Pharmaceutics (5 articles)
- Prodrugs in Pharmaceuticals (1 article)